Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Deloitte
Medtronic
Merck
Baxter
Cerilliant
Chubb
Teva

Generated: April 23, 2018

DrugPatentWatch Database Preview

CIDOFOVIR Drug Profile

« Back to Dashboard

Which patents cover Cidofovir, and what generic alternatives are available?

Cidofovir is a drug marketed by Emcure Pharms Ltd and Mylan Institutional and is included in two NDAs.

The generic ingredient in CIDOFOVIR is cidofovir. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cidofovir profile page.
Drug patent expirations by year for CIDOFOVIR
Pharmacology for CIDOFOVIR
Synonyms for CIDOFOVIR
({[(2S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine
(S)-(((1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonic acid
(S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid
(S)-HPMPC
(S)-HPMPC; Cidovir
[(1S)-1-[(4-amino-2-oxo-pyrimidin-1-yl)methyl]-2-hydroxy-ethoxy]methylphosphonic acid
[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
[1-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-propan-2-yl]oxymethylphosphonic acid
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
113852-37-2
120362-37-0 (hydrochloride salt)
394C661
768M1V522C
AB01566823_01
AC-1666
AC1L1TLB
AC1Q6C68
AKOS005145721
AKOS015854828
AN-14714
AN-8255
anhydrous cidofovir
API0002008
BC209905
BCP0726000147
BCP9000528
BDBM31915
BG0579
C8H14N3O6P
CAS-113852-37-2
CC0162
CDV
CHEBI:3696
CHEMBL152
Cidofovir (anhydrous)
Cidofovir (Vistide)
Cidofovir [INN]
Cidofovir anhydrous
Cidofovir gel
Cidofovir hydrate
cidofovir monophosphate
Cidofovir, anhydrous
Cidofovir,Vistide
Cidofovir(anhydrous)
Cidofovir(Vistide)
Cidofovirum
cidovir
CS-1669
D04AAW
DB00369
DSSTox_CID_23734
DSSTox_GSID_43734
DSSTox_RID_80069
DTXSID3043734
EBD21562
Forvade
Forvade (TM)
FT-0623818
GS 0504
GS 504
GS-0504
GS-504
GS-6438
GS504
HPMPC
HSDB 7115
HY-17438
J-502695
KB-302539
KS-00000XN7
L8P
LS-106432
MFCD00866936
MFCD17215968
MLS003915629
NCGC00184994-01
NCGC00184994-02
NCGC00184994-03
NSC-742135
NSC742135
Phosphonic acid, ((2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-, (S)-
Phosphonic acid, [[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-
Phosphonic acid,[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-
s1516
SCHEMBL3948
sidofovir
SMR002544687
SR-01000931969
SR-01000931969-2
Tox21_112994
UNII-768M1V522C
Vistide
Vistide (TN)
Vistide, Cidofovir
VWFCHDSQECPREK-LURJTMIESA-N
ZINC1530600

US Patents and Regulatory Information for CIDOFOVIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emcure Pharms Ltd CIDOFOVIR cidofovir INJECTABLE;INJECTION 202501-001 Jul 26, 2012 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Institutional CIDOFOVIR cidofovir INJECTABLE;INJECTION 201276-001 Jun 27, 2012 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Accenture
Chubb
US Army
Chinese Patent Office
US Department of Justice
Medtronic
Deloitte
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.